风湿免疫

订阅

MedSci主页 / 所有栏目 / 风湿免疫

干货！系统性红斑狼疮3大分类标准怎么选，这篇文章说清楚了

2021-11-15 Shielry MedSci原创

系统性红斑狼疮ACREULAR
关注

三大系统性红斑狼疮标准怎么选？新的标准一定更好吗？

系统性红斑狼疮（systemic lupus erythema-tosus, SLE）是一种经典的系统性自身免疫病。多系统受累，多变的临床症状，复杂的自身抗体和血清学的表现等因素使得SLE的诊断一直是风湿免疫科医生的一个难题。

从1997年ACR标准的提出到2012年的SLICC诊断标准以及最新的19年EULAR/ACR标准，他们的具体内容和特异性以及敏感性如何呢？

2019年EULAR/ACR

2020年《2020中国系统性红斑狼疮诊疗指南》中推荐用2012年国际狼疮研究临床协作组（SLICC）或2019年EULAR/ACR 制定的SLE分类标准对疑似SLE者进行诊断。

2019年EULAR/ACR指南采用入围与分类双重标准。将ANA阳性作为SLE分类诊断的“入围”标准，ANA阴性则不考虑诊断SLE。因为但在特定条件下，ANA阴性的SLE几乎不存在。

 

图片

最新的验证队列研究显示，此分类的敏感性为96%，特异性为93%，均为最优。

2012年SLICC标准

2012年的SLICC分类标准其更加强调临床表现和免疫学指标相结合，取消了部分特异性和敏感性不高的临床表现，且更重视系统受累，提高了肾活检在诊断中的重要性。

 

图片

针对新标准的诊断准确性研究显示，此SLE分类标准的敏感性为100%，特异性分别为 75%。显示成人 SLE 中2012 年 SLICC 分类标准相对最优。

1997年EULAR/ACR

1997年美国风湿病学会(ACR)分类标准是世界范围内最广泛应用于分类诊断SLE的标准。

 

图片

其校正之后的特异性和敏感性分别为0.93和0.83，由于敏感性相对较低，容易漏诊，不利于早期诊断。

怎样选择？

目前仅有1997年ACR的SLE分类标准曾在我国SLE人群中进行过验证，结果显示该标准对我国SLE患者具有良好的适用性。新的标准（2012年SLICC、2019年EULAR/ACR）在我国仍然需要更多的数据来验证新SLE标准的适用性。

最新的中国指南也推荐采用新的标准（2012年SLICC/2019 年EULAR/ACR）来进行SLE的诊断。

2012的SLICC标准有虽然有着较高的敏感度，但是特异性较低。

2019年的诊断标准不能诊断 ANA 持续阴性的 SLE，虽然这部分患者并不多见，但也需要探讨其他分类标准的可能性。

2019年的标准对于儿童特异性较低，有研究证实需要将19年的标准≥10分提高到≥13分，则可将其特异度提高到与ACR 1997和SLICC 2012标准相同的水平。

临床医生在选择诊断标准的时候还需要综合考虑，不能只选用最新的标准。必要的时候可以全都要。

参考文献

[1]杨航,刘毅.2019年EULAR/ACR系统性红斑狼疮分类标准解读——先“入围”再“分类”,诊断治疗更精准[J].西部医学,2019,31(11):1643-1645.
[2]宋红梅.儿童风湿病国际相关诊治指南系列解读之一——EULAR-ACR系统性红斑狼疮分类标准解读[J].中国实用儿科杂志,2020,35(04):249-252
[3]Hochberg Mc．Updating the American college of Rheumatology revised crite“a for the classification of systemic 1upus erythemato— sus[J]．Arthritis Rheum，1997(9)，40：1725．
[4]Aringer M，costenbader K，Daikh D，et．2019 European League Against Rheumatism／American C01lege of Rheumatology classification criteria for systemic lupus erythematosus[J]． Ann Rheum Dis，2019，78(9)：1151—1159．
[5]Petfi M，0rbai AM，Alarcon Gs，nf．De“vation and validation of the Systemic Lupus International Collaborating Clinics classifi— cation criteria for systemic lupus erythematosus[J]．Arth“tis Rheum，2012，64(8)：2677—2686．
[6].2020中国系统性红斑狼疮诊疗指南[J].中华内科杂志,2020(03):172-173-174-175-176-177-178-179-180-181-182-183-184-185.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2023-06-25 ms4000000304602592 来自贵州省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2022-07-17 qingrejiedu

    #系统性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2021-11-17 sunrural_42825357

    #狼疮#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2021-11-17 yytms

    #分类标准#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2021-11-17 zhouqu_8

    #红斑#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2144614, encodeId=112921446144e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a848636370, createdName=ms4000000304602592, createdTime=Sun Jun 25 11:20:08 CST 2023, time=2023-06-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2017310, encodeId=59d3201e310e4, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Jul 17 11:32:16 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387476, encodeId=62ad138e476f6, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422977, encodeId=190414229e7fc, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436307, encodeId=d0df143630e43, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Nov 17 00:32:16 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070373, encodeId=8ca410e0373e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Mon Nov 15 10:52:01 CST 2021, time=2021-11-15, status=1, ipAttribution=)]
    2021-11-15 含子

    学习了

    0

相关资讯

自身免疫和炎症性疾病与肠道微生物的关系研究

自身免疫性疾病和慢性炎症性疾病的特点是免疫反应失调，导致过度和不受控制的组织炎症。包括遗传变异、环境刺激和感染在内的多种因素都被认为是导致持续炎症和病理的因素

ARD：基因组测序和功能分析确定与系统性红斑狼疮相关MAP4K3/GLK种系和体细胞突变

T细胞中的MAP4K3 (GLK)过表达诱导白细胞介素(IL)-17A产生和自身免疫反应。SLE患者的多个GLK种系和体细胞突变通过增加mRNA或蛋白质稳定性诱导GLK过表达。

AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查

接受KRT的SLE患者的预后随着时间的推移而改善。需要KRT的SLE患者与因其他原因肾衰竭而需要KRT的患者相比，生存期相似。SLE患者肾移植后的生存率较差。

Rheumatology：系统性红斑狼疮合并双眼视网膜血管阻塞1例

合并视网膜血管阻塞作为系统性红斑狼疮的主要表现很少被报道，该文报道了一例19岁女性的SLE合并视网膜血管阻塞的病例

Clin Rev Allergy Immunol ：系统性红斑狼疮与妊娠：一项葡萄牙病例对照研究

系统性红斑狼疮(SLE)是一种危及生命的多系统自身免疫性疾病，影响育龄妇女。SLE患者的生育力没有降低，所以狼疮和怀孕之间的联系并不罕见，怀孕前密切跟踪SLE活动是妊娠成功的关键因素。

JEADV:系统性红斑狼疮患者甲带活动的研究

该文报道了一名系统性红斑狼疮(SLE)患者，在病程中出现的红色半月形指甲征变化过程。